Skip to main content
OpenTrials
Completed

NCT Number: NCT04417881

EVALUER L'IMPACT PREDICTIF DU SCORE MEESSI POUR LA STRATIFICATION DU RISQUE DES PATIENTS ADMIS POUR INSUFFISANCE CARDIAQUE AIGUE DANS LES STRUCTURES D'URGENCES

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

European Society of Cardiology recommend risk stratification for patients with AHF. MEESSI score is not prospectively validated out of Spain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acurate Heart Failure Disease Attributes Emergencies Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Jean Minjoz, Besançon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major patient
  • Patient admitted to emergencies with suspicion of ICA according to the clinical intuition of the emergency doctor after interrogation, clinical examination, biology and imaging
  • Patient with health insurance
  • Subject who accept to participate in the research

Exclusion criteria

  • Patient who refuse to participate in the study
  • Patient with coronary syndrome with ST segment elevation
  • Other diagnosis of dyspnea
  • Persons deprived of their freedom or under the protection of justice
  • Persons under guardianship or curatorship
  • Impossibility of giving the patient informed information
  • Pregnant woman

Treatment and study plan

MEESSI score

Other

MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

Primary outcomes

  1. MEESSI score

    Time frame: 30 days

    Tscore to predict the patient's future in the month following management for ED ICA. That is to say the number of days alive outside the hospital in the month following an ICA episode.

Secondary outcomes

  1. Re-admission rate

    Time frame: 30 days

    30-day re-admission rate compared between the 4 risk categories defined by the MEESSI score

  2. Mortality rate

    Time frame: 30 days

    Mortality rate at 30 days compared between the 4 risk categories defined by the MEESSI score

  3. Sensitivity

    Time frame: 30 days

    Sensitivity, specificity and ROC curve of the MEESSI score in relation to the composite criterion according to the 4 risk categories

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

EVALUER L'IMPACT PREDICTIF DU SCORE MEESSI POUR LA STRATIFICATION DU RISQUE DES PATIENTS ADMIS POUR INSUFFISANCE CARDIAQUE AIGUE DANS LES STRUCTURES D'URGENCES (ICA-MEESSI)

Acronym: ICA-MEESSI

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jun 5, 2020
Registry last updated
Oct 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.